The roundup is formatted with the title of the story, followed by the news source in parentheses and a brief summary. If you find a particularly interesting article, please send it to email@example.com for inclusion in next week’s roundup.
21st Century Cures:
The House of Representatives passed the 21st Century Cures Act on July 10th. The bill would provide an additional $1.86 billion per year in mandatory funding for the National Institutes of Health from fiscal 2016 to FY20.
21st Century Cures bill sails through House (Science Insider)
House overwhelmingly passes bill to speed FDA drug approvals (The Washington Post)
House approves Upton bill to boost disease research (The Detroit News)
House clears medical research bill with wide margin (The Baltimore Sun)
Rep. Rosa DeLauro: A flawed attempt to cure our country’s ills (New Haven Register) Rep. Rosa DeLauro, D-Mass., applauds the additional funding of NIH but cautions against relaxing drug and medical device approval from the Food and Drug Administration.
Cures in the Senate:
Attention turns now to the Senate to deliver medical cures legislation.
21st Century Cures Heads to the Senate (ASBMB Policy Blotter)
Cruz makes personal plea for Alzheimer’s research (The Hill) Sen. Ted Cruz, R-Texas, hosted a hearing Tuesday on “Unlocking Cures for America’s Most Deadly Diseases.”
Coburn: Cures bill ‘needs to do more’ (Washington Examiner) Former senator and physician, Tom Coburn participated in Sen. Cruz’s hearing on Tuesday and called for the Senate to “do more” to improve FDA approval process.
Alternative Science Funding Strategies in the News:
Congress pushes NIH to spur breakthroughs through prizes (Science Insider) Lawmakers find enthusiasm for research based competitions with hefty prize money following the models employed by engineering agencies.
Can we expect a MIRAcle for biomedical researchers in the US? (The Guardian) The National Institute for General Medical Sciences introduced a new pilot funding program called Maximizing Investigators’ Research Award that would fund investigators for 5 years.